Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus

This study has been terminated.
(Funding support withdrawn.)
Sponsor:
Collaborators:
Integrium
Msource Medical Development GmbH
Kinexum LLC
Thermo Fisher Scientific
Haupt Pharma Wülfing GmbH
BARC nv
Information provided by (Responsible Party):
N-Gene Research Laboratories, Inc.
ClinicalTrials.gov Identifier:
NCT01069965
First received: February 16, 2010
Last updated: September 26, 2014
Last verified: September 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2011
  Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)